Atinum Investment Co., Ltd (KOSDAQ:021080)
2,880.00
-150.00 (-4.95%)
At close: May 20, 2026
Atinum Investment Revenue
Atinum Investment had revenue of 3.46B KRW in the quarter ending September 30, 2013, with 193.07% growth. This brings the company's revenue in the last twelve months to 8.92B, up 7.48% year-over-year. In the year 2012, Atinum Investment had annual revenue of 5.67B, down -42.95%.
Revenue (ttm)
8.92B
Revenue Growth
+7.48%
P/S Ratio
16.04
Revenue / Employee
524.67M
Employees
n/a
Market Cap
143.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2012 | 5.67B | -4.27B | -42.95% |
| Dec 31, 2011 | 9.94B | 3.50B | 54.40% |
| Dec 31, 2010 | 6.44B | -225.00M | -3.38% |
| Dec 31, 2009 | 6.66B | -61.43B | -90.22% |
| Dec 31, 2008 | 68.09B | -3.39B | -4.74% |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IDIS Holdings | 908.09B |
| Unitrontech | 768.97B |
| ActRO | 244.94B |
| NEOOTO CO., | 232.12B |
| Kyung Dong Pharmaceutical | 196.27B |
| MDS Tech | 187.71B |
| TOPTEC | 171.00B |
| Wonik | 150.73B |
Atinum Investment News
- 1 year ago - Samsung Backs Scholarly AI Bot Serving Students and Academics - BNN Bloomberg